SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation

OBJECTIVE. Patients diagnosed with hematologic malignancies are at increased risk for severe SARS-CoV-2 infection. We evaluated the serological IgG response following two doses of the SARS-CoV-2 vaccine in patients with hematologic malignancies. METHODS. Patients treated at UT Southwestern Medical C...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoff, Fieke W., Goksu, Suleyman Y., Premnath, Naveen, Patel, Prapti A., Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Geethakumari, Praveen Ramakrishnan, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Weinberg, Olga K., Muthukumar, Alagarraju, Chung, Stephen S., Madanat, Yazan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Sciences and Arts of Bosnia and Herzegovina 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316070/
https://www.ncbi.nlm.nih.gov/pubmed/37326395
http://dx.doi.org/10.5644/ama2006-124.399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316070/
https://www.ncbi.nlm.nih.gov/pubmed/37326395
http://dx.doi.org/10.5644/ama2006-124.399

Ejemplares similares